URGN
UroGen Pharma Ltd. - Ordinary Shares (URGN)
$73
About UroGen Pharma Ltd. - Ordinary Shares (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$29.06
Daily low
$25.06
Price at open
$29.06
52 Week High
$50.81
52 Week Low
$16.50
Market cap
1.4B
Dividend yield
-
Volume
2.5M
Avg. volume
1.3M
P/E ratio
-14.41
UroGen Pharma Ltd. - Ordinary Shares News
Details
Daily high
$29.06
Daily low
$25.06
Price at open
$29.06
52 Week High
$50.81
52 Week Low
$16.50
Market cap
1.4B
Dividend yield
-
Volume
2.5M
Avg. volume
1.3M
P/E ratio
-14.41